Fenofibrate and diabetic retinopathy

The Lancet

Volumn 371, Issue 9614, 2008, Pages 721-722

  Cheung, Ning ^a   Wong, TY ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FENOFIBRATE; ANTILIPEMIC AGENT;

ATHEROSCLEROSIS; DIABETIC RETINOPATHY; DRUG EFFICACY; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; HUMAN; LETTER; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; VISUAL IMPAIRMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; DRUG EFFECT; LOW LEVEL LASER THERAPY; MICROCIRCULATION;

ANTILIPEMIC AGENTS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; HUMANS; PROCETOFEN; LASER THERAPY; MICROCIRCULATION;

EID: 39649091897     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)60333-5     Document Type: Letter

References (5)

1. Keech A., Mitchell P., Summanen P., et al., for the FIELD study investigators. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet 370 (2007) 1687-1697
2. The FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366 (2005) 1849-1861
3. Stokes K., and Granger D. The microcirculation: a motor for the systemic inflammatory response and large vessel disease induced by hypercholesterolaemia?. J Physiol 562 (2005) 647-653
4. Cheung N., Wang J., Klein R., Couper D., Sharrett A.R., and Wong T. Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care 30 (2007) 1742-1746
5. Wong T., Cheung N., Islam F., et al. The relationship of retinopathy to coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol 167 (2008) 51-58